Processa Pharmaceuticals, Inc. ( PCSA) - Stock Earnings
PCSA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
PCSA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.4 million USD | — USD |
| 2025Q4 | -3.4 million USD | — USD |
| 2026Q1 | -3.4 million USD | — USD |
| 2026Q4 Est. | — | — |
PCSA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -11.1 million USD | — USD |
| 2024 | -11.9 million USD | — USD |
| 2025 | -13.6 million USD | — USD |
| 2026 Est. | — | — |
PCSA
Price: $1.79
52 week price:
Earnings Per Share: -3.96 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 125600
Market Capitalization: 4.1 million